April 27-29, 2026
The Ritz-Carlton, Tysons Corner | McLean, VAKey Sessions
Lisa LeCointe-Cephas
Chairperson's Opening Remarks
Johnson & Johnson Innovative Medicine
Jill Fallows Macaluso
Keynote CCO: Organizational Value of Compliance
Novo Nordisk
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
2026 Day 2 Agenda - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
2026 Day 2 Agenda - ET (Eastern Time, GMT-05:00)
search
Streams
Formats
Showing 1 of 1 Streams
Registration
8:00am - 8:25am
Conference Registration and Continental Breakfast
Showing 1 of 1 Streams
Main Stage
8:25am - 8:40am
Chairperson's Opening Remarks
- Audience icebreaker activities during the Chair’s opening session
- Lisa LeCointe-Cephas - Chief Compliance Officer, Johnson & Johnson Innovative Medicine
8:40am - 9:30am
Global Compliance Officers Panel: Navigating Global Ethics and Compliance in the Face of Transformative Enforcement Shifts
- FCPA takeaways for updating risk management, internal investigations and compliance strategies
- Navigating tariffs and sanctions - how are compliance teams adapting to new geoeconomics trends
- What does it now take to manage a global team, keep everyone on the same page and tackle compliance calls?
- Establishing compliance standards across varied geographies: developing a core program with regional flexibility
- Kate Godfrey - Senior Vice President, Global Chief Compliance Officer, Karl Storz
- Leonardo Silva - Vice President, Chief Compliance & Privacy Officer, Ferring Pharmaceuticals
- Anisa Dhalla - Vice President and Chief Ethics and Compliance Officer, UCB
9:30am - 10:10am
Keynote CCO: Organizational Value of Compliance
- How do you define compliance value?
- What really matters to the Board, when showcasing the value of Compliance?
- Translating compliance activities into performance
- Jill Fallows Macaluso - Corporate Vice President & Chief Compliance Officer, Novo Nordisk
10:10am - 10:50am
CASE STUDY Turning Adversity into Opportunity: A Path to Transforming Culture and Compliance
Showing 1 of 1 Streams
Networking
10:50am - 11:20am
Networking Break
Showing 1 of 1 Streams
Main Stage
11:20am - 12:00pm
Former Prosecutors Panel - Interpreting the Latest DOJ Actions and Investigations
- Commentary on the latest developments from DOJ
- Update on DOJ’s health care fraud, FCPA, and other corporate enforcement
- DOJ guidance to prosecutors and its significance for pharmaceutical companies
- The current state of False Claims Act litigation
- Amanda Masselam Strachan - Partner, WilmerHale
12:00pm - 12:50pm
Law Firm Benchmarking Session - Chairs of Life Science Groups in Law Firms
- Analysis of the most recent Executive Orders impacting (Bio)pharmaceutical companies
- Implications of the Big, Beautiful Bill and Most Favoured Nations Pricing
- Update on FDA activity
- Litigation against the Administration
- Stefanie Doebler - Partner, Covington and Burling
Showing 1 of 1 Streams
Networking
12:50pm - 2:20pm
Networking Lunch
Showing 3 of 3 Streams
Topic Intensive A
Topic Intensive B
Topic Intensive C
2:20pm - 3:10pm
QUICK FIRE USE CASE AI Showcase
Get inspired with three rapid-fire, 10-minute case studies that deliver actionable insights. Learn how industry leaders tackle real-world challenges, uncover upside opportunities, and optimize resources for success.
- Aaron Leskow - Associate Director of Healthcare Compliance, Immunocore
2:20pm - 3:10pm
ADVANCED Global Harmonization of Compliance Standards: How Can Compliance Officers Align Across US, EU, and APAC Frameworks?
- Practical experience of navigating across different regions
- Strategies for ensuring organizational compliance effectiveness
- Suki Wiltman - Vice President, Global Ethics & Compliance, Ipsen Biopharmaceuticals (Subject to final confirmation)
- David Falcone - Vice President, Global Compliance, Merz Aesthetics
- Kirt Kraeuter - Executive Director, ERC Advisory, Policy & Learning, Novartis
2:20pm - 3:10pm
QUICK FIRE USE CASE Successful Compliance Communication Strategies in Action
Get inspired with three rapid-fire, 10-minute case studies that deliver actionable insights. Learn how industry leaders tackle real-world challenges, uncover upside opportunities, and optimize resources for success.
- Heather McCollum - Vice President, Compliance, Shionogi
- Jennifer Sanfilippo - General Counsel and Chief Compliance Officer, Melinta Therapeutics
- James Accumanno - Vice President, Legal & Chief Compliance Officer, Karyopharm Therapeutics
Showing 1 of 1 Streams
Networking
3:10pm - 3:50pm
Networking Break
Topic Intensives - Delve into the detail with practical scenarios and hands on approaches
Showing 3 of 3 Streams
Topic Intensive A
Topic Intensive B
Topic Intensive C
3:50pm - 4:55pm
Guardrails for Evolving Field Facing Roles
- How can we ensure we are communicating in every way we can communicate whilst remaining compliant?
- Interactions with GPOs – examining the types of interactions with field roles, what they can talk about and what can they do
- Medical commercial interactions: helping Compliance keep pace with agile approaches
- Considerations when using scientific platforms to engage HCPs
- Rore Middleton - Vice President, Compliance and Ethics, Blueprint Medicines
- Peter Agnoletto - Compliance Officer, General Medicines and Consumer Healthcare, Sanofi
4:55pm - 5:40pm
QUICK FIRE USE CASE Success Stories in Data Analytics
Get inspired with three rapid-fire, 10-minute case studies that deliver actionable insights. Learn how industry leaders tackle real-world challenges, uncover upside opportunities, and optimize resources for success.
- Sarah Venable - Head of Data Science and Risk Analytics, GSK
- Bryan Timer - Executive Director, Innovation, Digital Enablement, and Analytical Solutions, Merck
3:50pm - 4:55pm
ADVANCED SIUU Scientific Information on Unapproved Use(s) of Approved Medical Product Communications
- Nuances for communications for unapproved use of approved products
- What are people doing in the field? What is being allowed to be shared by Medical Science Liaison professionals (MLS) and practical guardrails that can be put into place
- Leonardo Silva - Vice President, Chief Compliance & Privacy Officer, Ferring Pharmaceuticals
- Mihaela Carsin - Compliance Business Lead, AstraZeneca
4:55pm - 5:40pm
ADVANCED Connecting Compliance and Holistic Risk Management
- Compliance’s role in strategic risk leadership
- Risk intelligence: translating compliance knowledge into strategic decision-making frameworks
- How to work collaboratively and cross functionally
- How is risk management informed by own monitoring and data, and all integrate together
- How are people handling risk assessment process: new ways of working
- Jackie Stanley - Digital, AI, and Privacy Compliance Team, Pfizer
- Blair Shaw - Vice President & Senior Compliance Officer, Cencora
- Eric Baim - Partner, Dovetail Consulting Group
3:50pm - 4:55pm
QUICK FIRE USE CASE Practical Training Ideas to Implement in your Organisation
Get inspired with three rapid-fire, 10-minute case studies that deliver actionable insights. Learn how industry leaders tackle real-world challenges, uncover upside opportunities, and optimize resources for success.
- Rachel Batykefer - Vice President, CIA and Compliance Operations, Mallinckrodt Pharmaceuticals
- Daniel O’Connor - Senior Vice President, NXLevel Compliance
4:55pm - 5:40pm
Market Access Risk Areas
- Navigating the payer and lobbying landscape for the Life Science industry
- Understanding areas of risk for market access activities
- Interplay between commercial teams, market access teams and Compliance
- Developing risk mitigation strategies
- Karen Lowney - Head of the Office of Ethics & Compliance (OEC), Sun Pharmaceutical Industries, Inc.
- Brandon Goodman - Vice President Legal, Global & Market Commercialization, BioNTech US
- Margaux Hall - Partner, Ropes & Gray
Showing 1 of 1 Streams
Networking
5:40pm - 5:45pm
Close of Day 2 Followed by Networking Reception
Filter
Streams
Formats